Does NIVOLUMAB Cause Hypophosphataemia? 69 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 69 reports of Hypophosphataemia have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.1% of all adverse event reports for NIVOLUMAB.
69
Reports of Hypophosphataemia with NIVOLUMAB
0.1%
of all NIVOLUMAB reports
17
Deaths
56
Hospitalizations
How Dangerous Is Hypophosphataemia From NIVOLUMAB?
Of the 69 reports, 17 (24.6%) resulted in death, 56 (81.2%) required hospitalization, and 15 (21.7%) were considered life-threatening.
Is Hypophosphataemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIVOLUMAB. However, 69 reports have been filed with the FAERS database.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Hypophosphataemia?
FERRIC CARBOXYMALTOSE (1,046)
ADEFOVIR DIPIVOXIL (368)
DENOSUMAB (322)
ZOLEDRONIC ACID (235)
LAMIVUDINE (205)
CYCLOPHOSPHAMIDE (196)
TENOFOVIR DISOPROXIL (192)
DEXAMETHASONE (186)
ACETAMINOPHEN (169)
LANSOPRAZOLE (159)
Which NIVOLUMAB Alternatives Have Lower Hypophosphataemia Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE